Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission

被引：11
作者：
Cherrier-De Wilde, S [1 ]
Rack, K
Vannuffel, P
Delannoy, A
Hagemeijer, A
机构：
[1] Hop Jolimont, Hematol Unit, Haine Saint Paul, Belgium
[2] Inst Pathol & Genet, Loverval, Belgium
[3] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium
来源：
LEUKEMIA | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1038/sj.leu.2403094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2046 / 2048
页数：3
相关论文
共 12 条
[1]   Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].
Andersen, MK ;
Pedersen-Bjorgaard, J ;
Kjeldsen, L ;
Dufva, IH ;
Brondum-Nielsen, K .
LEUKEMIA, 2002, 16 (07) :1390-1393
[2]  
Bose S, 1997, ACTA HAEMATOL-BASEL, V98, P155
[3]   Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones [J].
Chee, YL ;
Vickers, MA ;
Stevenson, D ;
Holyoake, TL ;
Culligan, J .
LEUKEMIA, 2003, 17 (03) :634-635
[4]  
Dawson L, 1999, BRIT J HAEMATOL, V106, P104
[5]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172
[6]   Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea [J].
Flamm, MJ ;
Murty, VVVS ;
Rao, PH ;
Nichols, GL .
LEUKEMIA RESEARCH, 2002, 26 (04) :417-420
[7]   Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].
Kantarjian, H ;
Sawyers, C ;
Hochhaus, A ;
Guilhot, F ;
Schiffer, C ;
Gambacorti-Passerini, C ;
Niederwieser, D ;
Resta, D ;
Capdeville, R ;
Zoellner, U ;
Talpaz, M ;
Druker, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652
[8]  
LIVAK KJ, 1995, PCR METH APPL, V4, P357
[9]   Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia [J].
Manley, R ;
Cochrane, J ;
McDonald, M ;
Rigby, S ;
Moore, A ;
Kirk, A ;
Clarke, S ;
Crossen, PE ;
Morris, CM ;
Patton, WN .
LEUKEMIA, 1999, 13 (01) :126-129
[10]   Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib [J].
Meeus, P ;
Demuynck, H ;
Martiat, P ;
Michaux, L ;
Wouters, E ;
Hagemeijer, A .
LEUKEMIA, 2003, 17 (02) :465-467
12